United States Huntington’s Disease Market and Competitive Landscape 2014-2023 - ResearchAndMarkets.com

October 10, 2018

DUBLIN--(BUSINESS WIRE)--Oct 10, 2018--The “US Huntington’s Disease Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Huntington’s Disease Market and Competitive Landscape - 2018, provides comprehensive insights into Huntington’s Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Huntington’s Disease market size and drug sales. This research also provides insights into Huntington’s Disease epidemiology and late stage pipeline.

The research is classified into following sections - Huntington’s Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Huntington’s Disease pipeline insights covering late stage clinical trials pipeline; Huntington’s Disease prevalence trends by countries; Huntington’s Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

Huntington’s Disease pipeline: Find out the drugs in clinical trials for Huntington’s Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Huntington’s Disease epidemiology: Find out the prevalence of Huntington’s Disease in US; prevalence forecast to 2023 Huntington’s Disease products: Identify key products marketed and prescribed for Huntington’s Disease by brand name, by molecule, by company, by branded / generic, in US Huntington’s Disease market size: Find out the market size for Huntington’s Disease drugs in US; Find out how the market advanced from 2014 Huntington’s Disease drug sales: Find out the sales of Huntington’s Disease drugs in US Huntington’s Disease drugs sales forecast: Sales forecast for Huntington’s Disease drugs to 2023 in US Huntington’s Disease market share analysis: Find out the market shares of Huntington’s Disease drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/9d23sz/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181010005802/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/10/2018 12:41 PM/DISC: 10/10/2018 12:41 PM


Update hourly